MERCK HDAC RES LLC has a total of 37 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are COGNITION PHARMACEUTICALS LLC, RYTEK and SEINFELD HUGO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | New Zealand | 6 | |
#4 | Japan | 5 | |
#5 | China | 4 | |
#6 | Canada | 2 | |
#7 | Russian Federation | 2 | |
#8 | Israel | 1 | |
#9 | Norway | 1 | |
#10 | Ukraine | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Miller Thomas A | 30 |
#2 | Richon Victoria M | 21 |
#3 | Chiao Judy H | 14 |
#4 | Bacopoulos Nicholas G | 10 |
#5 | Paradise Carolyn M | 10 |
#6 | Kelly W Kevin | 6 |
#7 | Chiao Judy | 3 |
#8 | Kelli V Kevin | 2 |
#9 | Witter David J | 2 |
#10 | Richon Viktorija M | 2 |
Publication | Filing date | Title |
---|---|---|
US2007213392A1 | Thiophene and benzothiophene hydroxamic acid derivatives | |
NZ560485A | Methods of treating cancer with HDAC inhibitors | |
US7456219B2 | Polymorphs of suberoylanilide hydroxamic acid | |
NZ568678A | Methods of inducing terminal differentiation using suberoylanilide hydroxamic acid (SAHA) |